Metabolic Syndrome, Physical Activity, and Medication-Related Expenditures: A Longitudinal Analysis

Metabolic syndrome (MetS) is a combination of risk factors for cardiovascular disease and type 2 diabetes mellitus. The prevalence of MetS worldwide is increasing. There is no study investigating the economic burden of MetS, especially in developing countries, on medication-related expenditure. The...

Full description

Saved in:
Bibliographic Details
Published in:Journal of physical activity & health 2019-10, Vol.16 (10), p.830-835
Main Authors: Lemes, Ítalo R, Fernandes, Rômulo A, Turi-Lynch, Bruna C, Codogno, Jamile S, de Morais, Luana C, Koyama, Kelly A K, Monteiro, Henrique L
Format: Article
Language:English
Subjects:
Exercise
Health care expenditures
Metabolic syndrome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metabolic syndrome (MetS) is a combination of risk factors for cardiovascular disease and type 2 diabetes mellitus. The prevalence of MetS worldwide is increasing. There is no study investigating the economic burden of MetS, especially in developing countries, on medication-related expenditure. The aim of this study was to investigate the association of medication-related expenditures with MetS and to explore how physical activity (PA) may influence this association. A total of 620 participants, 50 years or older, randomly selected in the city of Bauru, Brazil. Participants were followed from 2010 to 2014, and data on health care expenditure were collected annually. PA questionnaire was applied at baseline, 2 (2012), and 4 (2014) years later. Mean age was 64.7 (95% confidence interval, 64.1-65.3). MetS was associated with higher medication expenditure related to diseases of the circulatory (P
ISSN:1543-3080
1543-5474
DOI:10.1123/jpah.2018-0609